Citigroup
ORGO icon

Citigroup’s Organogenesis Holdings ORGO Stock Holding History

Citigroup’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Sell
7,175
-24,596
-77% -$85.2K ﹤0.01% 4874
2025
Q4 		$165K Sell
31,771
-5,685
-15% -$27.5K ﹤0.01% 4083
2025
Q3 		$158K Sell
37,456
-495
-1% -$2.3K ﹤0.01% 4089
2025
Q2 		$139K Sell
37,951
-33,766
-47% -$126K ﹤0.01% 4252
2025
Q1 		$310K Buy
71,717
+12,737
+22% +$51.4K ﹤0.01% 3933
2024
Q4 		$189K Buy
58,980
+4,396
+8% +$14.8K ﹤0.01% 4454
2024
Q3 		$156K Buy
54,584
+36,707
+205% +$103K ﹤0.01% 4524
2024
Q2 		$50.1K Buy
17,877
+2,157
+14% +$5.79K ﹤0.01% 4576
2024
Q1 		$44.6K Buy
15,720
+4,086
+35% +$13.9K ﹤0.01% 4685
2023
Q4 		$47.6K Buy
11,634
+11,026
+1,813% +$30.9K ﹤0.01% 4548
2023
Q3 		$1.93K Sell
608
-20,330
-97% -$64.6K ﹤0.01% 4967
2023
Q2 		$69.5K Buy
20,938
+18,707
+839% +$55.3K ﹤0.01% 4440
2023
Q1 		$4.75K Sell
2,231
-40,943
-95% -$101K ﹤0.01% 4956
2022
Q4 		$116K Buy
43,174
+9,022
+26% +$26.3K ﹤0.01% 3965
2022
Q3 		$111K Sell
34,152
-219,589
-87% -$992K ﹤0.01% 4041
2022
Q2 		$1.24M Buy
253,741
+163,787
+182% +$1.01M ﹤0.01% 2459
2022
Q1 		$686K Sell
89,954
-235,371
-72% -$1.82M ﹤0.01% 3286
2021
Q4 		$3.01M Buy
325,325
+200,959
+162% +$2.13M ﹤0.01% 2267
2021
Q3 		$1.77M Sell
124,366
-160,744
-56% -$2.5M ﹤0.01% 2626
2021
Q2 		$4.74M Buy
285,110
+283,491
+17,510% +$5.28M ﹤0.01% 1937
2021
Q1 		$29K Sell
1,619
-2,557
-61% -$34.6K ﹤0.01% 5028
2020
Q4 		$31K Buy
4,176
+3,204
+330% +$15.2K ﹤0.01% 6374
2020
Q3 		$4K Sell
972
-1,660
-63% -$6.55K ﹤0.01% 7135
2020
Q2 		$10K Sell
2,632
-240
-8% -$865 ﹤0.01% 7055
2020
Q1 		$9K Buy
2,872
+680
+31% +$2.91K ﹤0.01% 7080
2019
Q4 		$11K Buy
2,192
+1,670
+320% +$10.6K ﹤0.01% 7176
2019
Q3 		$4K Sell
522
-2,430
-82% -$13.5K ﹤0.01% 7397
2019
Q2 		$22K Sell
2,952
-2,527
-46% -$18.6K ﹤0.01% 7042
2019
Q1 		$41K Buy
+5,479
New +$109K ﹤0.01% 6491

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citigroup's ORGO Position: Q1 2026 in Review

Citigroup reduced its Organogenesis Holdings (ORGO) stake by 77% in Q1 2026, selling an estimated $85.2K and leaving 7,175 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #4874.

Citigroup first reported a position in ORGO in Q1 2019 and has held it in 29 quarters since. The position peaked at $4.74M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Citigroup held 7,175 shares of Organogenesis Holdings worth $17K as of Q1 2026.
  • Citigroup sold 24,596 Organogenesis Holdings shares in Q1 2026, an estimated $85.2K.
  • Organogenesis Holdings made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4874 holding.
  • Citigroup first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 29 quarters since.
  • Citigroup's Organogenesis Holdings position peaked at $4.74M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.